{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T10:44:55Z","timestamp":1782297895443,"version":"3.54.5"},"reference-count":68,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273863"],"award-info":[{"award-number":["82273863"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xphs.2025.103996","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T14:41:20Z","timestamp":1758292880000},"page":"103996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and evaluation of cyanocobalamin nasal powders for nasal delivery using biomimetic nasal cavity models"],"prefix":"10.1016","volume":"114","author":[{"given":"Yuting","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangying","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caifen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2025.103996_bib0001","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.chas.3c00069","article-title":"Nasal drug delivery system and devices: an overview on health effects","volume":"31","author":"Katare","year":"2024","journal-title":"ACS Chem Health Saf"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal drug delivery devices: Characteristics and performance in a clinical perspective\u2014a review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"10.1016\/j.xphs.2025.103996_bib0003","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3390\/pharmaceutics13060795","article-title":"A dry powder platform for nose-to-brain delivery of dexamethasone: formulation development and nasal deposition studies","volume":"13","author":"Nodilo","year":"2021","journal-title":"Pharmaceutics"},{"issue":"19","key":"10.1016\/j.xphs.2025.103996_bib0004","doi-asserted-by":"crossref","first-page":"13186","DOI":"10.1074\/jbc.R113.458810","article-title":"Navigating the B12 road: Assimilation, delivery, and disorders of cobalamin","volume":"288","author":"Gherasim","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.xphs.2025.103996_bib0005","doi-asserted-by":"crossref","first-page":"g5226","DOI":"10.1136\/bmj.g5226","article-title":"Vitamin B12 deficiency","volume":"349","author":"Hunt","year":"2014","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.xphs.2025.103996_bib0006","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3390\/molecules23051161","article-title":"Solubility of cyclodextrins and drug\/cyclodextrin complexes","volume":"23","author":"Saokham","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0007","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/pharmaceutics15010232","article-title":"Improving lurasidone hydrochloride's solubility and stability by higher-order complex formation with hydroxypropyl-beta-cyclodextrin","volume":"15","author":"Gamboa-Arancibia","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.103996_bib0008","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2010.04.029","article-title":"Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions","volume":"393","author":"Klang","year":"2010","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0009","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/acs.cgd.9b01457","article-title":"Sterol uptake by an alkali-beta-cyclodextrin metal-organic framework","volume":"20","author":"Blight","year":"2020","journal-title":"Cryst Growth Des"},{"key":"10.1016\/j.xphs.2025.103996_bib0010","first-page":"4449","article-title":"Nanocomplexes of an insulinotropic drug: Optimization, microparticle formation, and antidiabetic activity in rats","volume":"9","author":"Elmowafy","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.xphs.2025.103996_bib0011","article-title":"Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation","volume":"605","author":"Fasiolo","year":"2021","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0012","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jbm.b.31947","article-title":"In vivo evaluation of alginate microspheres of carvedilol for nasal delivery","volume":"100B","author":"Patil","year":"2012","journal-title":"J Biomed Mater Res B-Appl Biomater"},{"issue":"8","key":"10.1016\/j.xphs.2025.103996_bib0013","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1023\/A:1019881706159","article-title":"Insoluble powder formulation as an effective nasal drug delivery system","volume":"19","author":"Ishikawa","year":"2002","journal-title":"Pharm Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.103996_bib0014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5173(01)00736-0","article-title":"Improved nasal bioavailability of elcatonin by insoluble powder formulation","volume":"224","author":"Ishikawa","year":"2001","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0378-5173(01)00873-0","article-title":"In vivo evaluation of novel hyaluronan\/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits","volume":"231","author":"Lim","year":"2002","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.103996_bib0016","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2007.04.006","article-title":"Influence of fillers in powder formulations containing N-acetyl-(L)-cysteine on nasal peptide absorption","volume":"120","author":"Matsuyama","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.xphs.2025.103996_bib0017","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejps.2016.09.028","article-title":"Nasal drug absorption from powder formulations: the effect of three types of hydroxypropyl cellulose (HPC)","volume":"96","author":"Tanaka","year":"2017","journal-title":"Eur J Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.103996_bib0018","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0378-5173(00)00434-8","article-title":"Intranasal bioavailability of apomorphine from carboxymethylcellulose-based drug delivery systems","volume":"202","author":"Ugwoke","year":"2000","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0019","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.apsb.2023.06.007","article-title":"Visualization of nasal powder distribution using biomimetic human nasal cavity model","volume":"14","author":"Su","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.xphs.2025.103996_bib0020","author":"Ping"},{"key":"10.1016\/j.xphs.2025.103996_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105648","article-title":"Differences in the anatomy and physiology of the human and rat respiratory tracts and impact on toxicological assessments","volume":"150","author":"Stucki","year":"2024","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.xphs.2025.103996_bib0022","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2021.07.016","article-title":"A comparison of three mucus-secreting airway cell lines (Calu-3, SPOC1 and UNCN3T) for use as biopharmaceutical models of the nose and lung","volume":"167","author":"Lee","year":"2021","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2025.103996_bib0023","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaerosci.2016.01.013","article-title":"Modeling of inertial deposition in scaled models of rat and human nasal airways: Towards in vitro regional dosimetry in small animals","volume":"99","author":"Xi","year":"2016","journal-title":"J Aerosol Sci"},{"key":"10.1016\/j.xphs.2025.103996_bib0024","series-title":"Eurographics Italian chapter conference. Salerno","first-page":"129","article-title":"Meshlab: An open-source mesh processing tool","author":"Cignoni","year":"2008"},{"key":"10.1016\/j.xphs.2025.103996_bib0025","series-title":"Comput Appl Quant Methods Archaeol","first-page":"406","article-title":"Meshlab as a complete open tool for the integration of photos and colour with high-resolution 3D geometry data","author":"Callieri","year":"2012"},{"key":"10.1016\/j.xphs.2025.103996_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1038902","article-title":"Investigation of the potential of Glycyrrhiza glabra as a bioavailability enhancer of Vitamin B12","volume":"9","author":"Sharma","year":"2022","journal-title":"Front Nutr"},{"issue":"12","key":"10.1016\/j.xphs.2025.103996_bib0027","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.xphs.2022.10.003","article-title":"Elucidating a potential mechanism of permeability enhancer sodium n- 8-(2-hydroxybenzoyl) amino caprylate in rats: Evidence of lymphatic absorption of cyanocobalamin using the mesenteric lymph duct cannulated rat","volume":"111","author":"Chiang","year":"2022","journal-title":"J Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.103996_bib0028","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijpharm.2015.02.016","article-title":"In vivo application of chitosan to improve bioavailability of cyanocobalamin, a form of vitamin B12, following intraintestinal administration in rats","volume":"483","author":"Goto","year":"2015","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2025.103996_bib0029","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1440-1681.2005.04145.x","article-title":"Pharmacokinetics of high doses of cyanocobalamin administered by intravenous injection for 26 weeks in rats","volume":"32","author":"Nava-Ocampo","year":"2005","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"10.1016\/j.xphs.2025.103996_bib0030","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/ajcn\/nqaa221","article-title":"Measuring vitamin B12 bioavailability with 13C -cyanocobalamin in humans","volume":"112","author":"Devi","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.xphs.2025.103996_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102432","article-title":"Mucoadhesive and mucus-penetrating interpolyelectrolyte complexes for nose-to-brain drug delivery","volume":"37","author":"Porfiryeva","year":"2021","journal-title":"Nanomed: Nanotechnol Biol Med"},{"key":"10.1016\/j.xphs.2025.103996_bib0032","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejps.2018.06.032","article-title":"Synthesis of thiolated, PEGylated and POZylated silica nanoparticles and evaluation of their retention on rat intestinal mucosa in vitro","volume":"122","author":"Ways","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2025.103996_bib0033","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jps.2600740605","article-title":"Mechanism of nasal absorption of drugs I: Physicochemical parameters influencing the rate of in situ nasal absorption of drugs in rats","volume":"74","author":"Huang","year":"1985","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2025.103996_bib0034","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11095-011-0417-6","article-title":"Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast","volume":"28","author":"Kundoor","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2025.103996_bib0035","series-title":"Convention TUSP","first-page":"1557","article-title":"Pharmaceutical dosage forms","year":"2017"},{"issue":"22","key":"10.1016\/j.xphs.2025.103996_bib0036","first-page":"1685","article-title":"Research progress in intranasal drug delivery","author":"Yang","year":"2006","journal-title":"Chin J Pharm"},{"key":"10.1016\/j.xphs.2025.103996_bib0037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jphotobiol.2013.03.001","article-title":"Photodegradation of cobalamins in aqueous solutions and in human blood","volume":"122","author":"Juzeniene","year":"2013","journal-title":"J Photochem Photobiol B: Biol"},{"issue":"4","key":"10.1016\/j.xphs.2025.103996_bib0038","first-page":"329","article-title":"Effects of formulation variables and storage conditions on light protected vitamin B12 mixed parenteral formulations","volume":"4","author":"Monajjemzadeh","year":"2014","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.xphs.2025.103996_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jfoodeng.2023.111633","article-title":"Kinetics of vitamin B12 thermal degradation in cow's milk","volume":"357","author":"Ceribeli","year":"2023","journal-title":"J Food Eng"},{"issue":"5\u20136","key":"10.1016\/j.xphs.2025.103996_bib0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1024\/0300-9831\/a000578","article-title":"Sorbitol enhances the physicochemical stability of B12 vitamers","volume":"90","author":"Hadinata Lie","year":"2020","journal-title":"Int J Vitam Nutr Res"},{"issue":"22","key":"10.1016\/j.xphs.2025.103996_bib0041","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.3390\/molecules29225319","article-title":"Cyclodextrins: Advances in chemistry, toxicology, and multifaceted applications","volume":"29","author":"Musuc","year":"2024","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.xphs.2025.103996_bib0042","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/ph16091274","article-title":"Cyclodextrins for the delivery of bioactive compounds from natural sources: Medicinal, food and cosmetics applications","volume":"16","author":"Christaki","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"26","key":"10.1016\/j.xphs.2025.103996_bib0043","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1021\/acs.jafc.7b01562","article-title":"Antioxidant vitamin E\/cyclodextrin inclusion complex electrospun nanofibers: Enhanced water solubility, prolonged shelf life, and photostability of vitamin E","volume":"65","author":"Celebioglu","year":"2017","journal-title":"J Agric Food Chem"},{"issue":"3","key":"10.1016\/j.xphs.2025.103996_bib0044","doi-asserted-by":"crossref","first-page":"283","DOI":"10.24323\/akademik-gida.1187151","article-title":"Vitaminlerin nanoenkaps\u00fclasyonu ve nanoenkaps\u00fcle vitaminlerin sa\u011fl\u0131k \u00fczerine etkileri","volume":"20","author":"Saman","year":"2022","journal-title":"Akad G\u0131da"},{"issue":"7","key":"10.1016\/j.xphs.2025.103996_bib0045","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.xphs.2022.03.021","article-title":"Liquiritin-hydroxypropyl-beta-cyclodextrin inclusion complex: Preparation, characterization, bioavailability and antitumor activity evaluation","volume":"111","author":"Wang","year":"2022","journal-title":"J Pharm Sci"},{"issue":"23","key":"10.1016\/j.xphs.2025.103996_bib0046","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1021\/jp304594d","article-title":"Ultrafast infrared spectral fingerprints of vitamin B12 and related cobalamins","volume":"116","author":"Jones","year":"2012","journal-title":"J Phys Chem A"},{"issue":"3","key":"10.1016\/j.xphs.2025.103996_bib0047","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/ijms21030766","article-title":"Solubility enhancement of myricetin by inclusion complexation with heptakis-o-(2-hydroxypropyl)-\u03b2-cyclodextrin: A joint experimental and theoretical study","volume":"21","author":"Han","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2025.103996_bib0048","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.mssp.2015.03.009","article-title":"Preparation of vitamin B12\u2013TiO2 nanohybrid studied by TEM, FTIR and optical analysis techniques","volume":"35","author":"Gharagozlou","year":"2015","journal-title":"Mater Sci Semicond Process"},{"issue":"3","key":"10.1016\/j.xphs.2025.103996_bib0049","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/gels9030246","article-title":"Study of hydroxypropyl \u03b2-cyclodextrin and puerarin inclusion complexes encapsulated in sodium alginate-grafted 2-acrylamido-2-methyl-1-propane sulfonic acid hydrogels for oral controlled drug delivery","volume":"9","author":"Naeem","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.xphs.2025.103996_bib0050","first-page":"63","article-title":"optimization and in-vivo evaluation of cyanocobalamin loaded orodispersible films using hot-melt extrusion technology: A quality by design (QbD) approach","author":"Suryawanshi","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"issue":"10","key":"10.1016\/j.xphs.2025.103996_bib0051","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.3390\/molecules29102164","article-title":"Inclusion complexes of ethanamizuril with \u03b2- and hydroxypropyl-\u03b2-cyclodextrin in aqueous solution and in solid state: A comparison study","volume":"29","author":"Guo","year":"2024","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.xphs.2025.103996_bib0052","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1023\/A:1018869601502","article-title":"In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery","volume":"16","author":"Witschi","year":"1999","journal-title":"Pharm res"},{"issue":"3","key":"10.1016\/j.xphs.2025.103996_bib0053","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/15376516.2021.1977880","article-title":"Evaluation of Calu-3 cell lines as an in vitro model to study the inhalation toxicity of flavoring extracts","volume":"32","author":"Ji","year":"2022","journal-title":"Toxicol mech methods"},{"issue":"6","key":"10.1016\/j.xphs.2025.103996_bib0054","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.xphs.2024.01.013","article-title":"W\/O\/W microemulsions for nasal delivery of hydrophilic compounds: A preliminary study","volume":"113","author":"Cimino","year":"2024","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2025.103996_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120569","article-title":"Prediction of pharmacokinetic studies outcome for locally acting nasal sprays by using different in vitro methods","volume":"601","author":"Sibinovska","year":"2021","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0056","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/pharmaceutics12010079","article-title":"Comparison of various cell lines and three-dimensional mucociliary tissue model systems to estimate drug permeability using an in vitro transport study to predict nasal drug absorption in rats","volume":"12","author":"Furubayashi","year":"2020","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.xphs.2025.103996_bib0057","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.xphs.2020.04.016","article-title":"Evaluating the pharmacokinetics and systemic effects of a permeability enhancer sodium N-[8-(2-hydroxybenzoyl) amino] caprylate in rats","volume":"109","author":"Chiang","year":"2020","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2025.103996_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197101","article-title":"A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies","volume":"13","author":"Tan","year":"2018","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0059","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41598-017-18561-x","article-title":"Enhanced nasal drug delivery efficiency by increasing mechanical loading using hypergravity","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2025.103996_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122881","article-title":"Supramolecular cyclodextrin-based reservoir as nasal delivery vehicle for rivastigmine to brain","volume":"348","author":"Wang","year":"2025","journal-title":"Carbohydr Polym"},{"issue":"3","key":"10.1016\/j.xphs.2025.103996_bib0061","first-page":"253","article-title":"Effect of dead volume on the efficiency and the cost to deliver medications in cystic fibrosis with four disposable nebulizers","volume":"6","author":"Ho","year":"1999","journal-title":"Can Respir J"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0062","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40360-023-00711-9","article-title":"Evaluation of antibody drug delivery efficiency via nebulizer in various airway models and breathing patterns","volume":"24","author":"Hong","year":"2023","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0063","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12989-019-0290-8","article-title":"Correlation of regional deposition dosage for inhaled nanoparticles in human and rat olfactory","volume":"16","author":"Tian","year":"2019","journal-title":"Part Fibre Toxicol"},{"issue":"12","key":"10.1016\/j.xphs.2025.103996_bib0064","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1248\/bpb.24.1411","article-title":"Spray-dried powders as nasal absorption enhancers of cyanocobalamin","volume":"24","author":"Garcia-Arieta","year":"2001","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.xphs.2025.103996_bib0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5173(01)00736-0","article-title":"Improved nasal bioavailability of elcatonin by insoluble powder formulation","volume":"224","author":"Ishikawa","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2025.103996_bib0066","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejps.2017.09.027","article-title":"Opportunity and challenges of nasal powders: Drug formulation and delivery","volume":"113","author":"Tiozzo Fasiolo","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2025.103996_bib0067","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3390\/futurepharmacol3030038","article-title":"Cyclodextrin in vaccines: Enhancing efficacy and stability","volume":"3","author":"Varan","year":"2023","journal-title":"Future Pharmacol"},{"key":"10.1016\/j.xphs.2025.103996_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120728","article-title":"Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-\u03b2-cyclodextrin for budesonide nasal delivery","volume":"603","author":"Racaniello","year":"2021","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:04:53Z","timestamp":1769713493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925004502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022354925004502"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103996","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and evaluation of cyanocobalamin nasal powders for nasal delivery using biomimetic nasal cavity models","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"103996"}}